Breaking the body’s immune tolerance to tumors has been the biggest advance for cancer treatment in recent years. Now, scientists have reported that the same strategy might be successful against neurodegenerative diseases.

The notion that escape from immune surveillance could underlie both types of diseases is “counterintuitive on the surface, because one is a disease of proliferation and the other of neuronal death,” Michal Schwartz told BioWorld Today.

Originally published August 19, 2015 in Bioworld Today. For complete article, click here.

Share This